3M drops IBM healthcare software suit
20-02-2020
Boehringer Ingelheim teams up with IBM to explore blockchain
13-02-2019
IBM patent targets blockchain in open scientific research
14-11-2018
Jarretera / Shutterstock.com
The US Food and Drug Administration (FDA) has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Merck & Co, IBM, KPMG, Walmart, blockchain, technology, prescription drugs, DSCA
